Related Experiment Video

Updated: Jun 2, 2026

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions
10:27

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions

Published on: October 21, 2022

Circular RNAs as diagnostic biomarkers in type 2 diabetes mellitus: implications in metabolic dysfunction and

Zhaoxia Liu1, Hui Wu1, Qiaoshuang Pu1

  • 1General Medicine, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China.

Frontiers in Immunology
|June 1, 2026
PubMed

Insights

Circular RNAs (circRNAs) show promise for diagnosing type 2 diabetes mellitus (T2DM) and understanding its metabolic dysfunction. Further research is needed for clinical application in precision medicine.

Area of Science:

  • Biochemistry
  • Genetics
  • Endocrinology

Background:

  • Type 2 diabetes mellitus (T2DM) is a complex metabolic disorder with limited diagnostic tools.
  • Circular RNAs (circRNAs) are stable, non-coding RNAs with regulatory roles in disease.
  • circRNAs are emerging as potential biomarkers due to their stability and disease specificity.

Purpose of the Study:

  • To review the current understanding of circRNAs in T2DM.
  • To highlight the potential of circRNAs as diagnostic biomarkers for T2DM.
  • To explore the role of circRNAs in T2DM pathogenesis and metabolic dysfunction.

Main Methods:

  • Literature review of circRNAs in T2DM.
  • Analysis of circRNA involvement in insulin resistance, glucose metabolism, and inflammation.
  • Discussion of challenges and future directions in circRNA research.

Main Results:

  • circRNAs play roles in key T2DM processes like insulin resistance and beta-cell function.
  • circRNAs show potential as diagnostic biomarkers for T2DM.
  • Understanding circRNA networks (ceRNA) is crucial for T2DM research.

Conclusions:

  • circRNAs are promising for T2DM diagnosis and understanding disease mechanisms.
  • Future research should focus on validation, multicenter studies, and integrating advanced transcriptomic techniques.
  • Development of circRNA-based companion diagnostics could enable precision medicine for T2DM.
Keywords:
circular RNAscompeting endogenous RNA (ceRNA)diagnostic biomarkersmetabolic dysfunctiontype 2 diabetes mellitus

Related Concept Videos

Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...